drugset

Drugs / Ganwei

Follow last change Mar 2026 re-read 2 minutes ago

Ganwei

Traditional medicine (herbal / TCM) targets GNMT via activation

Developed for: NAFLD1 · herpes zoster
Investigated by: Taipei City Hospital · The One Biopharmaceutical Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

today NCT06244550 · not/applicable

20222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT06244550	Sep 2021 → Mar 2023	NAFLD1, fibrotic liver disease	Taipei City Hospital	Completed	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT06801509 Comparator	Feb → Nov 2025 overdue	herpes zoster	Sinocelltech Ltd.	Not yet recruiting	No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

Field	Value	Cited text
Known as	Ganwei	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06244550 ↗ 1 NCT06801509 ↗
Action	Activate	“Both metformin and Ganwei, health supplements containing a potent inducer of glycine N-methyltransferase (GNMT), have shown great promise for the treatment of MASLD.” PMID 41828627 ↗ Mar 2026
Modality	Traditional medicine (herbal / TCM)	“Ganwei compound herbal extract capsules contain extracts from natural foods such as Schisandra chinensis, Paeonia lactiflora, and Punica granatum.” NCT06244550 ↗
Route	Oral	“This trial aims to assess the impact of orally administering Ganwei compound herbal extract capsules on participants and evaluate its effects on fatty liver, liver fibrosis,...” NCT06244550 ↗
Target	GNMT	“Both metformin and Ganwei, health supplements containing a potent inducer of glycine N-methyltransferase (GNMT), have shown great promise for the treatment of MASLD.” PMID 41828627 ↗ Mar 2026